Thyrosafe Tablet
Product Images NDC 50633-910

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Thyrosafe (NDC 50633-910). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Btg International Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (65 mg Carton Label)

Principal Display Panel (65 mg Carton Label)
This is a drug facts label for Potassium Iodide (KI) tablets USP used for thyroid protection in a nuclear radiation emergency, for which taking emergency measures is recommended by public officials. These tablets contain lactose, magnesium stearate, and microcrystalline cellulose. It may cause an allergic reaction in the form of skin rash, swelling, shortness of breath, or fever. The label provides instructions for consumption by adults and children above 8 years. The tablets may be crushed and mixed with a liquid mixer, as the label shows. However, the text also advises consulting a doctor if a person is pregnant, breastfeeding, has a baby under one month, or has thyroid disease. It further instructs to store the tablets at 77°F and not to dispose of the consumer package insert.*
FDA Label Image

Principal Display Panel (65 mg Carton Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.